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Recent RNA interference (RNAi) studies have identified many host proteins that modulate virus
infection, but small interfering RNA ‘off-target’ effects and the use of transformed cell lines limit
their conclusiveness. As murine embryonic stem (mES) cells can be genetically modified and
resources exist where many and eventually all known mouse genes are insertionally inactivated, it
was reasoned that mES cells would provide a useful alternative to RNAi screens. Beyond allowing
investigation of host–pathogen interactions in vitro, mES cells have the potential to differentiate
into other primary cell types, as well as being used to generate knockout mice for in vivo studies.
However, mES cells are poorly characterized for virus infection. To investigate whether ES cells
can be used to explore host–virus interactions, this study characterized the responses of mES
cells following infection by herpes simplex virus type 1 (HSV-1) and influenza A virus. HSV-1
replicated lytically in mES cells, although mES cells were less permissive than most other cell
types tested. Influenza virus was able to enter mES cells and express some viral proteins, but the
replication cycle was incomplete and no infectious virus was produced. Knockdown of the host
protein AHCYL1 in mES cells reduced HSV-1 replication, showing the potential for using mES
cells to study host–virus interactions. Transcriptional profiling, however, indicated the lack of an
efficient innate immune response in these cells. mES cells may thus be useful to identify host
proteins that play a role in virus replication, but they are not suitable to determine factors that are
involved in innate host defence.
INTRODUCTION
Viruses are obligate intracellular parasites that hijack the
host’s cellular machinery during their replication cycle.
RNA interference (RNAi) screens have proved a very
powerful tool for reducing expression of host genes during
infection with many different viruses, including influenza
virus and human immunodeficiency virus, thereby iden-
tifying host proteins that affect virus replication. Such host
genes can be grouped into virus replication dependence
factors (VRDFs), those host proteins that are required for
virus replication, and virus restriction factors (VRFs), those
host proteins that block virus infection (Brass et al., 2008;
Karlas et al., 2010; Ko¨nig et al., 2010; Krishnan et al., 2008;
Zhou et al., 2008). However, problems with RNAi methods
can give ‘off-target’ effects or incomplete knockdown.
Furthermore, variation between RNAi studies examining
the same virus can be influenced by the cell line, virus
strain and methodology, resulting in a lack of overlap
between the RNAi gene sets identified (Bartz & Jackson,
2005; Watanabe et al., 2010; Zhou et al., 2008). The use of
classical genetic screens, through insertional inactivation in
haploid cells, has recently identified VRDFs to influenza
virus; however, the unusual karyotype of chronic lympho-
blastic leukaemia may limit this approach (Carette et al.,
2009).
Ultimately, the functional validation of RNAi results
requires either the identification of corresponding gene
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defects in the authentic host or the production of knockout
(KO) mice and assessment of virus infection. Importantly,
comparison of murine and human genomes has shown
that there is a homologue for ~99 % of murine genes in the
human genome (Chinwalla et al., 2002). An international
programme where KOs for all genes of the mouse are being
produced is under way (Austin et al., 2004), as well as
infection challenge studies in different mouse strains (Boon
et al., 2011), and this is now supported by the complete
genome sequences of 17 mouse strains (Keane et al., 2011;
Yalcin et al., 2011). In addition, the four members of the KO
mouse consortium, namely the European Conditional
Mouse Mutagenesis Programme (EUCOMM; http://www.
knockoutmouse.org/about/eucomm), the Knockout Mouse
Programme (http://www.komp.org), the Canadian North
American Conditional Mouse Mutagenesis Project (http://
www.norcomm.org) and the Texas Institute for Genomic
Research (http://www.tigm.org), have produced 10 000
heterozygous KO murine embryonic stem (mES) cells and
hundreds of homozygous KO mice, many of which are of
interest because the genes have been identified previously as
VRFs or VRDFs in viral screens. Furthermore, recent
advances in gene targeting strategies have also resulted in
the ability to produce inducible homozygous mutant mES
cells (Li et al., 2010; Tate & Skarnes, 2011). This raises the
possibility of using murine KO mES cells both for random
library screening and for confirmation experiments before
deriving KO mice. mES cells are derived from the inner cell
mass of blastocysts, and are self-renewing and remain
pluripotent if cultured under the correct conditions. They
can also be differentiated into many cell types, such as
neuronal, dendritic and hepatic cell lineages (Bibel et al.,
2004; Fairchild et al., 2000; Soto-Gutie´rrez et al., 2007),
offering great potential for investigating viruses with specific
cell tropisms.
Previous work has demonstrated that mES cells can be used
for studying cellular interactions with bacterial pathogens.
After exposure of mES cells to Salmonella enterica, Shigella
flexneri or Escherichia coli, the bacteria were detected in
intracellular locations similar to those observed for
differentiated cells. In comparison with wild-type mES
cells, infection of mES cells defective in a gene required for
cholesterol biosynthesis resulted in lower levels of bacterial
replication, showing the potential of using KO mES cells
for looking at bacteria–host interactions (Yu et al., 2009).
In addition, it has been demonstrated that human ES (hES)
cells are susceptible to coxsackievirus B and produce viable
virus particles (Scassa et al., 2011). However, apart from
work with retroviral vectors (Wang & Bradley, 2007), less is
known about the ability of human viruses to productively
infect and replicate in mES cells. Here, we characterized
virus infection of mES cells using influenza A virus and
herpes simplex virus type 1 (HSV-1). These viruses were
selected because they are important human pathogens
(Deshpande et al., 2000; Schoenbaum, 2001) for which
RNAi screens have been carried out (Brass et al., 2009;
Karlas et al., 2010), they are known to infect other murine
cell lines (Bolovan et al., 1994; Shinya et al., 2004) and they
have well-defined mouse models (Matsuoka et al., 2009;
Mester & Rouse, 1991).
We showed that mES cells are permissive for HSV-1 but
restrict the full influenza virus replication cycle. KO of an
HSV-1 dependency factor in mES cells resulted in
attenuated HSV-1 replication, demonstrating the use of
mES cells as a genetic resource for host–virus interactions.
However, the lack of innate immune responses following
infection suggests that mES cells are not suitable for
determining factors that are involved in innate host
defence.
RESULTS
Entry of HSV-1 and influenza into mES cells
We assessed the ability of HSV-1 and influenza virus A/
WSN/33 to infect the wild-type mES cell line JM8A1.N3.
HSV-1 infection was detected through GFP expression
under the control of the cytomegalovirus (CMV) imme-
diate-early 1 (IE1) promoter in HSV-1 C12 (Fig. 1a). The
stem cell phenotype of JM8A1.N3 was maintained during
infection, as determined by the maintenance of expres-
sion of SSEA-1, a surface antigen that is a marker for
undifferentiated murine stem cells (Fig. 1a). Similarly,
entry and initiation of viral gene expression by influenza
virus was confirmed by detection of NP expression at 24 h
post-infection (p.i.) in mES cells (Fig. 1a). HSV-1 infection
of JM8A1.N3 cells increased with higher m.o.i., with an
m.o.i. of 10 resulting in 80 % of the mES cells expressing
virus-driven GFP by 24 h p.i. (Fig. 1b).
Following infection of mES cells with HSV-1 or A/WSN/
33, a cytopathic effect was observed by 24 h p.i., with cells
rounding up and detaching from the culture vessels. For
HSV-1-infected cells, viability remained similar to that of
mock-infected cells at 24 h p.i. (data not shown) but
decreased significantly as assessed by cellular ATP levels by
48 h p.i. at an m.o.i. of 1 and 5 (Fig. 1c, P¡0.001).
Infection with influenza also caused a loss in cell viability,
even at lower m.o.i. and as early as 24 h p.i. (Fig. 1d,
P¡0.0002).
Viral protein production in mES cells
Uninfected mES cells grow in discrete colonies, rather than
monolayers, with the cells having large nuclei and minimal
cytoplasm (Fig. 2a). Following infection of mES cells, we
examined the extent of HSV-1 gene expression using
antibodies against HSV-1 ICP27, ICP8 and glycoprotein C
(gC), which are immediate-early (IE), early (E) and late (L)
gene products, respectively, using immunofluorescent
microscopy. The majority of cells expressing virus-encoded
GFP also co-expressed the HSV-1 IE, E and L viral proteins
(Fig. 2b). As expected, expression of ICP8 and ICP27 were
observed in the nuclei of infected cells (Fig. 2c–e), whilst
Virus infection of murine embryonic stem cells
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Fig. 1. (a) Flow cytometric detection of stage-specific embryonic antigen-1 (SSEA-1) expression in mES cells at 24 h after
infection with HSV-1 (GFP) at an m.o.i. of 1 (upper panel) or nucleoprotein (NP) expression in mES cells at 24 h after infection
with influenza virus A/WSN/33 at m.o.i. of 0.1 (lower panel). (b) HSV-1 infection at different m.o.i. assessed by flow cytometric
detection of GFP expression from HSV-1 in mES cells. Samples were taken in triplicate and analysed at 24 h p.i. Results are
shown as means±SD. (c) mES cell viability after HSV-1 infection. Cells were infected in suspension with HSV-1 at an m.o.i. of
0.5, 1 and 5. Viability was assessed at 48 h p.i. using a CellTiter-Glo kit. A significant decrease was seen (P¡0.001) for
samples infected at m.o.i. of 1 and 5 when compared with mock-infected samples (Student’s t-test). (d) mES cell viability after
A/WSN/33 infection. Cells were infected in suspension with A/WSN/33 at an m.o.i. of 0.01 or 0.1. Viability was assessed at 24
(open bars) and 48 (shaded bars) h p.i. A significant decrease was seen (P¡0.0002) for both treatments when compared with
mock-infected samples (Student’s t-test).
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gC was expressed predominantly on the cell surface (Fig.
2f). mES cells infected at the same m.o.i. as baby hamster
kidney (BHK-21) and murine embryonic fibroblast feeder
(SNLP 76/7-4) cells expressed less viral protein at 6 and
24 h p.i. (Fig. 3a). HSV-1 gB and gC glycosylation was
defective in mES cells. Precursor gB and gC proteins were
clearly expressed by 24 h; however, glycosylated high-
molecular-mass gB and gC proteins were not detected (Fig.
3a). For influenza virus infection, viral protein expression
in mES cells was severely reduced in comparison with fully
permissive Madin–Derby canine kidney (MDCK) or SNLP
76/7-4 cells. Although NP, M1 and NS1 expression was
observed at 10 h p.i., no expression was detectable by 24 h
by Western blotting (Fig. 3b).
Replication of HSV-1 and influenza virus in mES
cells
We determined whether HSV-1 could form spreading
infections in mES cell by flow cytometric analysis of
infected cells. For HSV-1 infection at an m.o.i. of 1 (based
on the titre of the virus in BHK-21 cells), GFP expression
increased over the 53 h following infection, reaching a
maximum of 63 % of cells expressing GFP by this time (Fig.
4a). The majority of the virus was cell associated (Fig. 4b).
We confirmed full virus lytic replication and spreading
infection by inhibiting HSV-1 replication with acyclovir
(ACV) or 1-(29deoxy-29-fluoro-1-b-D-arabinofuranosyl)-
5-iodo-uracil (FIAU), with both virus replication inhibi-
tors significantly reducing HSV-1 replication (Fig. 4c).
Electron micrographs of HSV-1-infected mES cells (Figs S1
and S2, available in JGV Online) revealed HSV-1 intra-
cellular particles in nuclear virus factories, associated with
the nuclear membrane and at the cell surface. We assessed
the spread of influenza virus infection both in mES cells
growing as clumps and by infecting disrupted mES cells in
suspension. As this was performed in the presence of serum
needed to maintain the mES cells in their undifferentiated
state, a trypsin-independent strain of influenza virus (A/
WSN/33) (Goto & Kawaoka, 1998) was used. Irrespective
of mES cell culture type, influenza virus failed to establish a
spreading infection (Fig. 4d). We therefore concluded that
mES cells support HSV-1 replication but not influenza A
virus replication.
Host response to infection
mES cells are reported to be defective in an interferon
response when infected by bacteria. Virus infection is a
powerful inducer of type I interferons, as many virus
components are recognized by pattern recognition recep-
tors. We therefore used gene expression profiling of HSV-
1- and influenza virus-infected mES cells at an early time
point after infection to investigate whether innate immune
responses were induced in mES cells. Hierarchal clustering
analysis demonstrated that the expression profiles of HSV-
1- and influenza virus A/WSN/33-infected mES cell
samples clustered in groups distinct from mock-infected
mES cells (Fig. 5a). Following infection, .200 genes were
expressed differentially in virus-infected mES cells (Fig.
5b). Although there was some overlap between the host
genes affected by HSV-1 and A/WSN/33, they were not
necessarily regulated in the same direction. Whilst the
majority of changes following HSV-1 infection were due to
upregulation of genes, in A/WSN/33-infected mES cells a
different pattern was observed and more genes were
downregulated (Fig. 5c, d). Functional analysis of genes
that exhibited significant changes showed that HSV-1
infection induced the upregulation of transcriptional
processes, whereas infection with A/WSN/33 induced
downregulation of transcriptional processes (Table 1). No
downregulated genes were found to be functionally
enriched in HSV-1-infected cells or upregulated genes for
(a)  
 
 
 
 
  
  
(b)
(c) (d)
(f)(e)
Fig. 2. Confocal microscopy of HSV-1-infected mES cells at 24 h
p.i. GFP expression from HSV-1 infection was visible as green
fluorescence, HSV-1 gene-specific antibody staining was shown
by red fluorescence and mES cell nuclei were stained with DAPI
(blue). (a) DAPI-stained mES cell nuclei. (b) GFP-expressing HSV-
1-infected mES cells. (c) HSV-1 ICP8 staining with DyLight 549.
(d) Merged image of (a), (b) and (c). (e) Merged image for HSV-1-
infected mES cells with HSV-1 ICP27 staining. (f) Merged image
for HSV-1-infected mES cells with HSV-1 glycoprotein C staining.
Bars, 20 mm (d, e); 10 mm (f).
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influenza virus-infected cells. Use of the INTERFEROME
database identified five upregulated genes for HSV-1 and
nine for A/WSN/33 that are involved in the type I interferon
response (Table 2).
Knockdown of host genes and virus infection
We investigated whether mES cells knocked out for a gene
identified in RNAi screens (Karlas et al., 2010) and shown
previously to be necessary to support HSV-1 replication
(S. J. Griffiths, M. Koegl, C. Boutell, H. L. Zenner, C. M.
Crump, O. Gonzalez, C. C. Friedel, G. Barry, K. Martin,
M. H. Craigon, R. Chen, L. N. Kaza, E. Fossum, J. K.
Fazakerley, S. Efstathiou, R. Zimmer, P. Ghazal and J.
Haas, unpublished data) produced an analogous pheno-
type. Heterozygote KO mES cells for Ahcyl1 (Ahcyl1+/2)
expressed reduced levels of AHCYL1 protein (Fig. 6a, lane
3) relative to wild-type mES cells (Fig. 6a, lanes 1 and 2).
Ahcyl1+/2 cells still supported HSV-1 replication but with
reduced HSV-1 ICP4 and gC expression (Fig. 6a, lane 3), as
well as a significantly reduced output viral titre (Fig. 6b;
P,0.001). Further knockdown of Ahcyl1 using an RNAi
pool resulted in undetectable levels of the protein but did
not further reduce ICP4 and gC expression following HSV-
1 infection (Fig. 6a, lane 4). However, the loss of detectable
AHCYL1 expression led to a further significant reduction
in the titre of replicated virus (Fig. 6b; P,0.05).
To confirm the requirement of AHCYL1 for HSV-1
replication, we used small interfering RNA (siRNA)
knockdown of AHCYL1 in a human cell line. Following
transfection, siRNA depletion of AHCYL1 mRNA levels
was confirmed by quantitative PCR (qPCR) (Fig. 6c).
Replication of HSV-1 in HeLa cells transfected with
AHCYL1, RNA-induced silencing complex (RISC)-free
(negative control), ICP4 (essential HSV-1 gene) or VP11/
12 (non-essential HSV-1 gene) siRNAs was compared, with
replication being normalized to that of mock-transfected
cells (Fig. 6d). When either the essential HSV-1 ICP4 gene
or AHCYL1 was knocked down, reductions of more than
threefold in HSV-1 replication were observed.
DISCUSSION
Here, we showed that murine embryonic stem cells support
infection with HSV-1 and influenza virus. HSV-1 was able
gB 
Fully glycosylated 
BHK-21 mES  SNLP-76/74 
Mock Mock Mock HSV-1 HSV-1 HSV-1 
Precursor 
gC 
Fully glycosylated 
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MDCK mES  SNLP-76/74 
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1 2 3 4 5 6 7 8 9
1 2 3 4 5 6 7 8 9 10 11 12
 Mock Mock WSN WSN WSN 
M1 
NP 
β -Actin  
NS1 
ICP8 
ICP27 
β -Actin  
(a)
(b) 
Fig. 3. (a) Western blot analysis of cells
infected with HSV-1 C12. BHK-21, mES or
SNLP-76/7-4 cells were infected at an m.o.i.
of 1 and cell lysates were collected at 6 (lanes
1, 3, 5, 7, 9 and 11) or 24 (lanes 2, 4, 6, 8, 10
and 12) h p.i. Membranes were probed with
HSV-1-specific antibodies against ICP27,
ICP8, gB and gC, followed by secondary
antibody conjugated to HRP. (b) Western blot
analysis of cells infected with A/WSN/33
(WSN). MDCK, mES or SNLP-76/7-4 cells
were infected at an m.o.i. of 1 and cell lysates
were collected at 10 (lanes 2, 4 and 6) or 24
(lanes 1, 3, 5 and 7–9) h p.i. Membranes were
probed with influenza-specific antibodies, fol-
lowed by secondary antibody conjugated to
HRP. Antibody against b-actin was used as a
loading control in both experiments.
R. Wash and others
2122 Journal of General Virology 93
(a) (b)
(c) (d)
100
80
60
40
20
H
S
V
-1
-in
fe
ct
ed
 c
el
ls
 (%
 G
FP
)
0
H
S
V
-1
 ti
tr
e 
(p
.f.
u.
)
H
S
V
-1
 ti
tr
e 
(p
.f.
u.
)
In
flu
en
za
 ti
tr
e 
(p
.f.
u.
)
5×105
5×104
5×103
5×102
1×102
5×105
5×104
5×103
1×103
1×106
1×104
1×102
1×100
0 20 40
Time (h p.i.)
60 80 0
0
20
20 30 40 501024 48
40
Time (h p.i.)
Time (h p.i.)Time (h p.i.)
60 80
Fig. 4. (a) HSV-1 infection kinetics in mES cells infected at an m.o.i. of 1. Samples were taken from 0 to 76 h p.i. and GFP
expression by infected cells was analysed by flow cytometry. (b) Generation of productive virus was also quantified by plaque
assays of infected mES cell lysates ($) and culture medium (m) on BHK-21 cells. (c) Inhibition of HSV-1 replication (m.o.i. of 1)
in mES cells using 44.4 mM ACV or 0.2 mM FIAU. Cell lysates were harvested at 24 and 48 h p.i. and the generation of
productive virus was quantified by plaque assay on BHK-21 cells. ACV, Dark grey-shaded columns; FIAU, mid-grey-shaded
columns; no drug, light grey-shaded columns. (d) A/WSN/33 infection kinetics in mES cells infected in suspension at an m.o.i.
of 0.2. Samples of culture medium were taken at 6, 24 and 48 h p.i. and generation of productive virus was quantified by plaque
assay on MDCK cells. Input virus is indicated by a dashed line.
Table 1. Enrichment analysis (DAVID) of significantly expressed genes in HSV-1- and influenza virus A/WSN/33-infected mES cells at
6 h p.i.
Biological process No. genes Total genes (%) Enrichment score P value
HSV-1-upregulated genes
Regulation of transcription 49 8.78 14.26 1.3610238
Regulation of transcription from
RNA polymerase II promoter
38 6.81 10.33 2.30610241
Transcription 26 4.66 3.51 6.40610214
Nucleosome assembly 5 0.9 3.12 7.70610210
Protein amino acid
dephosphorylation
6 1.08 2.5 3.80610211
Nuclear division 8 1.43 2.08 7.40610213
A/WSN/33-downregulated genes
Regulation of transcription 15 8.52 2.36 1.20610210
Virus infection of murine embryonic stem cells
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Fig. 5. Microarray analysis of mES cells
infected with HSV-1 or A/WSN/33, at 6 h
p.i. (a) Hierarchical clustering of mock-infected
samples compared with HSV-1- or A/WSN/
33-infected samples. Infections were set up in
triplicate and mock samples were taken from
two independent experiments. The scale bars
show Pearson correlation coefficients. (b)
Venn diagrams of all significantly differentially
expressed genes in mES cells infected with
HSV-1 or A/WSN/33. Data were analysed
using Significance Analysis for Microarrays (d
value of 1.5, false discovery rate ,0.025, fold
change ¢1.5). (c) Comparison of significantly
upregulated genes only. (d) Comparison of
significantly downregulated genes only.
Table 2. Type I interferon-regulated genes, from the INTERFEROME database, that were significantly upregulated in HSV-1- or influenza
virus A/WSN/33-infected mES cells at 6 h p.i.
Gene Description Fold change
HSV-1-upregulated genes
Tbx3 T-box 3 1.55
Trex1 Three prime repair exonuclease 1 1.58
Tuba1c Tubulin-a1C 1.82
Wdr43 WD repeat domain 43 1.61
Zfp36 Zinc finger protein 36 3.46
A/WSN/33-upregulated genes
Chka Choline kinase a 1.85
Eif2s2 Eukaryotic translation initiation factor 2, subunit 2 (b) 1.53
H2afj H2A histone family, member J 1.52
Ifngr2 Interferon-c receptor 2 2.21
Lgals4 Lectin, galactose binding, soluble 4 4.34
Prf1 Perforin 1 (pore forming protein) 2.78
Rbbp4 Retinoblastoma binding protein 4 1.51
Traf4 Tumour necrosis factor receptor associated factor 4 1.66
Ube2n Ubiquitin-conjugating enzyme E2N 2.24
R. Wash and others
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to complete its replication cycle in mES cells, although they
were less permissive than other cell lines. HSV-1 is able to
replicate efficiently in non-human cells; however, the
observed delayed expression of gC in mES cells and the
expression of precursor but not glycosylated gC and gB
proteins may contribute to reduced replication (Wenske &
Courtney, 1983). HSV-1 gC has an important role in
adsorption of HSV-1 to cells, and gC deletion mutants show
reduced infectivity (Herold et al., 1991). It has been observed
that both mES and hES cells have different glycosylation
profiles compared with differentiated cells derived from
them (Atwood et al., 2008; Satomaa et al., 2009). It may be
the case that the other HSV-1 glycoproteins are not fully
matured in mES cells, thereby affecting the ability of HSV-1
to replicate to high titre in these cells.
In contrast, influenza A virus, whilst capable of entering the
cells and initiating viral gene expression, failed to complete its
life cycle. Viral NP, M1 and NS1 were expressed at very low
levels and for a limited duration in mES cells. In addition, it
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Fig. 6. (a) Protein extracts from mES cells were analysed by Western blotting after treatment with siRNA for 48 h followed by
HSV-1 infection (m.o.i. of 0.5). Membranes were probed with antibodies specific for AHCYL1, HSV-1 ICP4 (6 h p.i.) and HSV-
1 gC (24 h p.i.). Antibody against b-actin was used as a loading control. (b) Generation of productive HSV-1 at 24 h p.i. in mES
cells transfected with siRNA 48 h prior to infection. Student’s t-test was performed. WT, Wild-type mES cells; Ahcyl+/”, mES
cells with heterozygous knockout for Ahcyl1; No, no RNAi; NT, non-targeting siRNA pool; KD, knockdown with Ahcyl1-specific
siRNA pool. (c) siRNA depletion reduces mRNA expression levels of AHCYL1 in HeLa cells. mRNA expression levels of
AHCYL1 at 48 h post-transfection were quantified by Taqman qPCR, normalized to the housekeeping gene hypoxanthine
phosphoribosyltransferase 1 (HPRT1) and calibrated against mock-transfected cells. Mean gene knockdown is presented, with
error bars representing SD of technical duplicates. (d) RNAi perturbation screen by kinetic analysis of HSV-1 replication. HeLa
cells were reverse transfected with siRNA SMARTpools (four siRNAs per gene). After 48 h, the siRNAs were tested for
cytotoxicity (three replicates) or the capacity to influence replication of the HSV-1 GFP reporter virus C12 (six replicates) from
24 to 80 h p.i. Replication was normalized to mock-transfected cells and compared with replication following knockdown of
essential (ICP4, VP16) or non-essential (VP11/12) viral genes, or control RISC-free siRNA (not shown). HSV replication is
presented as the normalized replication slope and is the mean±SD of six individual assay points.
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has been demonstrated that changes in glycosylation of the
viral haemagglutinin can hinder virus replication (Wagner
et al., 2000). Therefore, the unusual glycosylation profile
of the mES cells may have affected haemagglutinin and
neuraminidase maturation and could have been a further
factor in the failure of influenza virus A/WSN/33 to produce a
spreading infection. However, infection with influenza virus,
even at low m.o.i., still affected the viability of mES cells.
Microarray analysis of HSV-1-infected mES cells showed
that genes involved in transcription processes were upregu-
lated following infection. This has also been observed in
murine and human differentiated cell lines that are
permissive for HSV-1 infection (Kamakura et al., 2008;
Pasieka et al., 2006). In contrast, we observed that fewer
genes were expressed differentially when mES cells were
infected with influenza virus A/WSN/33, and genes that were
enriched for transcriptional processes were downregulated.
This may have been because influenza replication was
restricted in these cells. Although a few genes that are part of
the type I interferon response were upregulated following
viral infection, there was an obvious lack in the expression of
genes that are classically involved in innate immune
responses to viral infection, such as nuclear factor-kB, type
I interferons, interleukins and interferon regulatory factors
(Geiss et al., 2001; Kamakura et al., 2008). This result was
not unexpected, as significant upregulation of genes
involved in the immune response were also not induced
when hES or mES cells were infected with bacteria (Fo¨ldes
et al., 2010; Yu et al., 2009). This may be because
transcription in ES cells is tightly regulated so that they
remain pluripotent, and such regulation also includes
interferon-stimulated genes (Szutorisz et al., 2006; Yu et al.,
2009).
As HSV-1 can complete its full replication cycle, the
potential of using high-throughput and robust mouse
genetics techniques to investigate the role of host factors
in virus replication becomes possible. Here, we demon-
strated this utility and showed that heterozygous Ahcyl1 KO
mES cells with RNAi knockdown of the remaining expressed
allele could identify host genes required to support efficient
HSV-1 replication. Work by S. J. Griffiths et al. (unpub-
lished data, as above) where siRNA knockdown of AHCYL1
inhibited HSV-1 replication, and interaction between
AHCYL1 and HSV-1 UL10 (gM) occurred in a yeast two-
hybrid screen revealed that AHCYL1 may be a host factor
involved in HSV-1 replication.
AHCYL1 is a cytosolic protein that inhibits the inositol
1,4,5-trisphosphate (IP3) receptor, antagonizing IP3-
induced Ca2+ release from the endoplasmic reticulum, as
well as regulating intracellular pH by interacting with Na+/
HCO23 co-transporters (Devogelaere et al., 2008). IP3-
induced calcium release is required for HSV-1 infection
(Cheshenko et al., 2003, 2007). Although the mechanism of
how AHCYL1 supports HSV-1 replication is unknown, it
seems that control of Ca2+ signalling is required to facilitate
HSV-1 replication in different cell types. The generation of
an Ahcyl1 KO mouse from Ahcyl1+/2 mES cells will be
important for further characterization of this gene.
We showed here that mES cells may be used to investigate
host–virus interactions, but we suggest that an initial
detailed characterization of mES permissivity for replica-
tion of the virus of interest is essential before this system is
used. If the cells are not fully replication permissive, they
are still of value as they can be used to identify host factors
involved in the early stages of virus replication, similar to
previous work using Drosophila cells in an influenza screen
(Hao et al., 2008). Importantly, the use of Blm-deficient
mES cells for the generation of random homozygous
mutant libraries is a potentially powerful means of
identifying VRDFs for viruses that infect mES cells (Li
et al., 2010; Wang & Bradley, 2007). However, although
mES cells may be useful for identifying VRDFs or VRFs
involved in the mechanics of replication, due to the lack of
an innate immune response to viral infection they are not
appropriate for determining host factors that influence
replication through innate immunological mechanisms.
METHODS
Cell culture. All cell lines were cultured in a humidified atmosphere
with 5 % CO2 at 37 uC. MDCK cells were obtained from the ATCC
and cultured in Dulbecco’s modified Eagle’s medium with glutaMAX
(DMEM; Gibco) with 10 % FBS (Biosera), 100 U penicillin ml21
(Gibco) and 100 mg streptomycin ml21 (Gibco). BHK-21 cells were
also grown in this medium supplemented with 10 % tryptose
phosphate broth solution (Sigma-Aldrich). The JM8 mES cells used
were derived from the Agouti C57BL/6 mouse strain, substrain N.
Cells were cultured in KO DMEM (Invitrogen) supplemented with
10 % FBS (Invitrogen), 2 mM L-glutamine (Invitrogen), 0.1 mM b-
mercaptoethanol (Sigma) and 1000 U leukocyte inhibitory factor
(Chemicon) ml21 (M10 medium). JM8 mES cells that had been gene
targeted in a critical exon for Ahcyl1 to generate a heterozygous KO
cell line were cultured in M10 medium supplemented with 100 mg
G418 (Gibco) ml21. SNLP 76/7-4 cells were cultured in KO DMEM
supplemented with 7 % FBS (Invitrogen), 2 mM L-glutamine
(Invitrogen) and 0.1 mM b-mercaptoethanol (Sigma). Prior to
seeding mES or feeder cells, flasks or plates were coated with 0.1 %
gelatine (type B; Sigma) in PBS for 10 min.
Viruses and infection. HSV-1 C12, a variant that has a CMV IE1
promoter–EGFP cassette inserted at the US5 gene locus from pEGFP-
C1 (Clontech), was used for these experiments (Arthur et al., 2001).
Virus stocks were propagated and assayed on confluent BHK-21 cells.
Influenza virus A/WSN/33, a human virus that was mouse adapted in
the 1940s (Hoffmann et al., 2011; Ward, 1996), was also used. Virus
stocks were propagated in embryonated chicken eggs and assayed on
confluent MDCK cells, as described previously (Hutchinson et al.,
2008).
For infection experiments, cell monolayers were overlaid with a
minimal volume of medium containing the appropriate m.o.i. of
virus. After 1 h incubation, the inoculum was discarded and replaced
with a suitable volume of culture medium. For some infections, virus
was added directly to the cell suspensions and left in the culture
medium, where indicated. At defined time points p.i., samples of cell-
culture medium or infected cells were collected. Infected cells were
lysed by three freeze–thaw cycles to release virus prior to assays. For
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drug inhibition, 44.4 mM ACV or 0.2 mM FIAU was added to the
culture medium after the HSV-1 adsorption period.
Plaque assays. Material to be assayed was serially diluted in serum-
free DMEM and used to infect either BHK-21 cells for HSV-1 or
MDCK cells for influenza virus WSN/33 in 12-well plates. After 1 h
incubation, the inoculum was removed and the cells overlaid with
DMEM containing either 5 % FBS and 0.6 % carboxymethylcellulose
(Sigma-Aldrich) for HSV-1, or 0.2 % BSA (Sigma-Aldrich), 1.25 %
avicel (FMC Biopolymer) and 1 mg trypsin ml21 treated with L-
(tosylamido-2-phenyl) ethyl chloromethyl ketone (Worthington
Biochemical Corp.) for A/WSN/33 (Matrosovich et al., 2006). After
2–3 days, the overlay was removed and the cells fixed with 4 %
formaldehyde solution for 20 min before being stained with 0.1 %
toluidine blue solution (Sigma-Aldrich) so that the number of p.f.u.
could be calculated.
Flow cytometry. All flow cytometric analysis was carried out using a
FACScalibur (Becton Dickinson). A minimum of 10 000 gated events
was acquired and analysed using CellQuest software (BD Biosciences).
Antibodies were supplied by Abcam unless stated otherwise. HSV-1-
infected cells were fixed in 3 % formaldehyde and detected by
expression of GFP. For SSEA-1 surface staining, cells were incubated
with SSEA-1 conjugated to phycoerythrin (BD Biosciences) diluted
1 : 10 in staining buffer (1 % FBS in PBS) for 1 h at 4 uC in the dark.
Cells were washed twice with staining buffer and fixed for 20 min at
4 uC in 4 % paraformaldehyde (USB Corp.), followed by a further two
washes with staining buffer. Intracellular staining was used for
detection of influenza NP expression in influenza virus-infected mES
cells. A Cytofix/Cytoperm kit (BD Biosciences) was used following the
manufacturer’s instructions, with the cells being incubated with anti-
NP antibody (diluted 1 : 500), followed by incubation with a goat
anti-mouse IgG secondary antibody conjugated to DyLight 488
(1 : 100).
Confocal microscopy. JM8A1.N3 cells were grown on gelatine-
coated coverslips in a 12-well plate (2.56105 cells per well) and
infected with HSV-1 at an m.o.i. of 0.1. The cells were fixed with 2 %
paraformaldehyde for 30 min with continuous shaking. After washing
twice with PBS, the cells were permeablized with 0.2 % Triton X-100
(Sigma-Aldrich) for 10 min at room temperature. Another washing
step was performed with PBS containing 0.5 % BSA (Gibco) before
the cells were immunostained with mAbs specific for one of the IE
(ICP27, 1 : 1000), E (ICP8, 1 : 1000) or L (gC, 1 : 25 600) proteins of
HSV-1 for 1–2 h on a shaker at room temperature. The cells were
washed with PBS containing 5 % BSA and then incubated with a goat
anti-mouse IgG secondary antibody conjugated to DyLight 549
(1 : 2000). After another washing step, the coverslips were mounted
with ProLong Gold containing DAPI (Invitrogen) onto microscope
slides. Analysis was performed using a LSM 510 META confocal
microscope (Zeiss).
Electron microscopy. Infected tissues were fixed in 2 % para-
formaldehyde with 2.5 % glutaraldehyde in 0.1 M sodium cacodylate
buffer (pH 7.42) with added 0.1 % MgCl2 and 0.05 % CaCl2 at 20 uC
for 15 min and then incubated on ice for 45 min. Samples were then
fixed in 1 % osmium tetroxide in sodium cacodylate buffer for 1 h at
room temperature, mordanted with 1 % tannic acid for 30 min,
stained en bloc with 2 % uranyl at the 30 % ethanol stage during
dehydration and embedded in Agar 100 resin. Ultrathin sections
(60 nm) were cut on a Leica UC6 ultramicrotome, contrast-stained
with uranyl actetate and lead citrate and imaged on a 120 kV FEI
Spirit Biotwin with a Tietz F4.15 CCD camera.
Western blotting. Cells were lysed with RIPA buffer (Sigma-Aldrich)
containing a protease inhibitor cocktail (Thermo Scientific) for 5 min
on ice. The cell debris was removed by performing high-speed
centrifugation for 10 min at 17949 g at 4 uC. Total protein was
quantified using a BCA assay (Thermo Scientific) and normalized
before use. Samples were mixed with 26 protein loading buffer
(National Diagnostics) and heated for 10 min at 95 uC. The proteins
were separated by SDS-PAGE (4–15 % Mini-PROTEAN TGX Precast
Gel; Bio-Rad) under denaturing conditions and transferred to
nitrocellulose membranes by wet blotting at 100 V for 1 h. The
membrane was blocked with PBS with 0.05 % Tween 20 containing
5 % skimmed milk powder (blocking buffer) for at least 1 h at room
temperature or overnight at 4 uC. Primary antibodies were diluted in
blocking buffer and incubated with the membranes on a shaker for
1 h at room temperature. HSV-1-specific mAbs against the following
proteins were used: ICP27 (1 : 1000), ICP4 (1 : 10 000), ICP8
(1 : 1000), gB (1 : 12 800) and gC (1 : 3200). Influenza-specific mAbs
against NP (1 : 1000) and M1 (1 : 1000) and polyclonal rabbit antisera
specific to NS1 (1 : 500) (Carrasco et al., 2004) were used. Antibodies
specific for the host protein AHCYL1 (1 : 1000) were used to confirm
levels of expression in mES cells. An antibody specific for b-actin
(1 : 1000) was used as a loading control. Membranes were washed
three times with PBS containing 0.05 % Tween 20 before being
incubated for 1 h with secondary antibody conjugated to HRP diluted
in blocking buffer (goat anti-mouse–HRP, 1 : 4000, Southern Biotech;
or swine anti-rabbit–HRP, 1 : 3000, DakoCytomation). After further
washing steps, ECL Plus Western blotting detection reagent (GE
Healthcare) was added to the membranes and they were then exposed
to high-performance autoradiography film (GE Healthcare).
Expression microarray analysis. mES cells were grown in six-well
plates and mock-infected (M10 medium only) or infected with HSV-
1 (m.o.i. of 5) or influenza virus A/WSN/33 (m.o.i. of 2). At 6 h p.i.,
RNA was extracted from the cells using an RNeasy Mini Plus kit
(Qiagen) and normalized to equal mass across all samples. Probe
labelling and hybridization were performed using an Illumina Mus
musculus 6v2 microarray following the manufacturer’s instructions.
The array probe summaries were calculated in BeadStudio (Illumina)
and quantile normalized. Data were analysed using MultiExperiment
Viewer (TM4 Microarray Software Suite; Saeed et al., 2003, 2006),
applying a variance filter with a SD cut-off of 0.1. Functional analysis
of genes that were expressed differentially was performed using the
ontology tool Database for Annotation, Visualization and Integrated
Discovery (DAVID) (Huang et al., 2008, 2009). Significantly upregu-
lated genes were also compared with the INTERFEROME database
(Samarajiwa et al., 2009). The microarray data are publicly available
in ArrayExpress under accession numbers E-MTAB-882 and E-
MTAB-883.
Cell viability. For determination of cell viability, ATP from
metabolically active cells was measured using a CellTiter-Glo
luminescent assay (Promega) following the manufacturer’s instruc-
tions. Briefly, 16104 mES cells per well in 50 ml M10 medium were
seeded in gelatinized, white opaque 96-well plates. An additional 50 ml
M10 medium containing virus was added to the plates as follows.
Cells were mock-infected (M10 only) or infected with HSV-1 at m.o.i.
of 0.5, 1 or 5 or with influenza virus A/WSN/33 at m.o.i. of 0.01 or
0.1. Infections were carried out in triplicate. After 24 or 48 h
incubation at 37 uC and 5 % CO2, 100 ml CellTiter-Glo reagent per
well was added. After 2 min on a shaker followed by 10 min
incubation at room temperature, the luminescence was recorded
using a FLUOstar Omega (BMG Labtech) with an integration time of
0.24 s per well. The luminescence signals of virus-infected cells were
compared with those of mock-infected cells to determine the effect of
infection on cell viability.
RNAi knockdown in mES cells. RNAi transfection mixes were set
up according to the manufacturer’s instructions. Briefly, 3 ml Lipofec-
tamine RNAiMAX (Invitrogen) was combined with ON-TARGET
plus SMART pool mouse Ahcyl1 or non-targeting siRNAs (Thermo
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Scientific) at a final concentration of 50 nM in opti-MEM (Invitrogen)
for 20 min at room temperature. Wild-type (JM8A1.N3) or heterozyg-
ous KO Ahcyl1+/2mES cells (EPD0336_2_C12 Ahcyl1tm1a(EUCOMM)Wtsi;
Skarnes et al., 2011) were plated at 36105 per well in gelatine-coated
12-well plates followed by the addition of transfection mixes. The
medium was changed daily, with a sample of cells being harvested at
48 h post-transfection to confirm gene knockdown by Western
blotting. At 48 h post-transfection, cells were also infected with HSV-
1 at an m.o.i. of 0.5. Samples of cell lysates were collected at 24 h p.i.
and the viral titre was determined by plaque assays.
RNAi knockdown in HeLa cells. siRNA SMARTpools at 0.3 mM
were dispensed in 10 ml volumes using a Rapidplate384 liquid handler
(Qiagen) into triplicate black 384-well plates (Corning), sealed with
adhesive seals (ThermoFisher) and plate lids, and stored at 280 uC
until needed (minimum 24 h, maximum 48 h). On the day of
transfection, assay plates were thawed at room temperature and 10 ml
transfection reagent (Dharmafect 1; Dharmacon), diluted in Hanks’
buffered saline solution (ThermoFisher) to give a final concentration
of 0.1 %, was added using a Multidrop 384 (ThermoFisher). Plates
were incubated for 20 min at room temperature to allow formation of
transfection complexes. During complex formation, low-passage
(passage 20–22) HeLa cells (ECACC) from ~50 % confluent flasks
were washed in PBS and trypsinized in trypsin/EDTA (Lonza) before
diluting in phenol red-free, antibiotic-free transfection medium
[DMEM/F-12 (1 : 1) with 5 % FCS with 15 mM HEPES and L-
glutamine; Gibco]. Using the Multidrop 384, 36103 cells in 40 ml
medium were added to each well. Plates were incubated for 48 h at
37 uC and 5 % CO2 before infection. For infection, the medium was
removed from the plates by inversion, and 10 ml medium only or
HSV-1 (m.o.i. of 0.5) was added using the Multidrop 384. Plates were
incubated at 37 uC for 1 h before 50 ml medium was added and the
plates returned to the incubator prior to monitoring virus replication.
Replication was monitored as a function of EGFP fluorescence from
24 to 80 h p.i. using a POLARstar OPTIMA plate reader (BMG
Labtech). Virus replication slopes over the linear phase were
calculated and normalized to transfected wells on individual assay
plates, and the mean replication slope from six replicates was used for
subsequent data analyses.
qPCR for siRNA knockdown in HeLa cells. HeLa cells were mock-
transfected or transfected with AHCYL1 SMARTpool siRNAs in 96-
well plates, in triplicate, as described above. After 48 h transfection, the
medium was removed and the cells rinsed in PBS and lysed in 100 ml
TRIzol (Invitrogen). Triplicate wells were combined and RNA was
extracted by standard phenol/chloroform extraction methods. TaqMan
qPCR was used to determine mRNA levels, using a one-step RT-qPCR
kit (Thermofisher), with AHCYL1-specific primers (59-TGGTGTG-
TGGCTATGGTGAG-39 and 59-GGGGTCGATTTCGGTAATGT-39)
and probes from the Universal Probe Library (Roche). Expression
levels were normalized to the housekeeping cellular gene HPRT1 (59-
TGACCTTGATTTATTTTGCATACC-39 and 59-CGAGCAAGACGT-
TCAGTCCT-39) and calibrated against mock-transfected cells. qPCR
was carried out in duplicate for each sample, and the mean level of
normalized expression levels was determined.
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